These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 28941127)
1. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience. Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127 [TBL] [Abstract][Full Text] [Related]
2. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve. Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408 [TBL] [Abstract][Full Text] [Related]
3. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study. Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039 [TBL] [Abstract][Full Text] [Related]
4. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience. Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967 [TBL] [Abstract][Full Text] [Related]
5. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement. Seeger J; Gonska B; Rottbauer W; Wöhrle J Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290 [TBL] [Abstract][Full Text] [Related]
6. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis. Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207 [TBL] [Abstract][Full Text] [Related]
7. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis. Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473 [TBL] [Abstract][Full Text] [Related]
8. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort. Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976 [TBL] [Abstract][Full Text] [Related]
9. A feasibility study of transaxillary TAVI with the lotus valve. Doshi SN; George S; Kwok CS; Mechery A; Mamas M; Ludman PF; Townend JN; Bhabra M Catheter Cardiovasc Interv; 2018 Sep; 92(3):542-549. PubMed ID: 29130619 [TBL] [Abstract][Full Text] [Related]
10. Single-center evaluation of a next generation fully repositionable and retrievable transcatheter aortic valve replacement. Berntorp K; Koul S; Nozohoor S; Harnek J; Bjursten H; Götberg M BMC Cardiovasc Disord; 2019 Feb; 19(1):44. PubMed ID: 30808296 [TBL] [Abstract][Full Text] [Related]
11. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family. Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431 [TBL] [Abstract][Full Text] [Related]
12. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve. Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152 [TBL] [Abstract][Full Text] [Related]
13. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort. Schulz E; Jabs A; Tamm A; Herz P; Schulz A; Gori T; von Bardeleben S; Kasper-König W; Hink U; Vahl CF; Münzel T Int J Cardiol; 2017 Apr; 232():186-191. PubMed ID: 28089455 [TBL] [Abstract][Full Text] [Related]
14. First North American experience with the transfemoral ACURATE-neo Bagur R; Teefy PJ; Kiaii B; Diamantouros P; Chu MWA Catheter Cardiovasc Interv; 2017 Jul; 90(1):130-138. PubMed ID: 27677241 [TBL] [Abstract][Full Text] [Related]
15. Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort). Blackman DJ; Meredith IT; Dumonteil N; Tchétché D; Hildick-Smith D; Spence MS; Walters DL; Harnek J; Worthley SG; Rioufol G; Lefèvre T; Houle VM; Allocco DJ; Dawkins KD Am J Cardiol; 2017 Jul; 120(2):292-299. PubMed ID: 28535962 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of three different new generation transcatheter aortic valve prostheses. Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073 [TBL] [Abstract][Full Text] [Related]
17. Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications. Conzelmann LO; Würth A; Balthasar V; Neuber C; Tzamalis P; Gonska BD; Schmitt C; Mehlhorn U; Schymik G Catheter Cardiovasc Interv; 2020 Jan; 95(1):E21-E29. PubMed ID: 31115146 [TBL] [Abstract][Full Text] [Related]
18. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study. Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084 [TBL] [Abstract][Full Text] [Related]
19. Valve embolization with a second-generation fully-retrievable and repositionable transcatheter aortic valve. Giannini F; Montorfano M; Romano V; Ruparelia N; Jabbour RJ; Benincasa S; Latib A; Colombo A Int J Cardiol; 2016 Nov; 223():867-869. PubMed ID: 27580223 [TBL] [Abstract][Full Text] [Related]
20. First experience with transfemoral transcatheter aortic valve implantation without prior balloon pre-dilatation using a latest generation repositionable and retrievable transcatheter heart valve†. Schaefer A; Harmel E; Seiffert M; Reichart D; Deuschl F; Schofer N; Schneeberger Y; Blankenberg S; Reichenspurner H; Schaefer U; Conradi L Interact Cardiovasc Thorac Surg; 2017 May; 24(5):659-662. PubMed ID: 28329312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]